Ruoxin Lan
Overview
Explore the profile of Ruoxin Lan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang X, Lan R, Liu Y, Pillarisetty V, Li D, Zhao C, et al.
NPJ Precis Oncol
. 2025 Mar;
9(1):58.
PMID: 40032924
Neoadjuvant therapy (NAT) is increasingly being used for pancreatic ductal adenocarcinoma (PDAC). This study investigates how NAT differentially impacts PDAC's carcinoma cells and the tumor microenvironment (TME). Spatial transcriptomics was...
2.
Li D, Liu Y, Lan R, Pillarisetty V, Zhang X, Liu Y
Virchows Arch
. 2025 Feb;
PMID: 40014118
Neoadjuvant therapy (NAT) is the standard of care for borderline-resectable and locally advanced pancreatic ductal adenocarcinoma (PDAC). It can be used to treat resectable PDAC. This study aimed to investigate...
3.
Al-Adra D, Lan R, Jennings H, Weinstein K, Liu Y, Verhoven B, et al.
Transpl Immunol
. 2024 Aug;
86:102104.
PMID: 39128812
Background: Normothermic ex vivo liver perfusion (NEVLP) is an exciting strategy to preserve livers prior to transplant, however, the effects of NEVLP on the phenotype of tissue-resident immune cells is...
4.
Zhang X, Lan R, Liu Y, Pillarisetty V, Li D, Zhao C, et al.
Res Sq
. 2024 May;
PMID: 38798691
Background: Neoadjuvant therapy (NAT) is increasingly being used for pancreatic ductal adenocarcinoma (PDAC) treatment. However, its specific effects on carcinoma cells and the tumor microenvironment (TME) are not fully understood....
5.
Liu Y, Al-Adra D, Lan R, Jung G, Li H, Yeh M, et al.
Hepatol Commun
. 2022 Mar;
6(8):2170-2181.
PMID: 35344307
Dysregulation of expression of functional genes and pathways plays critical roles in the etiology and progression of hepatocellular carcinoma (HCC). Next generation-based RNA sequencing (RNA-seq) offers unparalleled power to comprehensively...
6.
Lan R, Ge D, Liu Y, You Z
Biochem Biophys Rep
. 2022 Jan;
29:101200.
PMID: 35036586
Growth differentiation factor 5 () and doublecortin () genes are both expressed in joint interzone cells during synovial joint development. In this study, we re-analyzed the single cell RNA-sequencing data...
7.
Lan R, Jin B, Liu Y, Zhang K, Niu T, You Z
Am J Clin Exp Urol
. 2020 Sep;
8(4):116-128.
PMID: 32929407
F-box and WD repeat domain containing (FBXW) family of E3 ligases has 10 members that ubiquitinate substrate proteins for proteasome-mediated degradation. Publicly archived datasets from The Cancer Genome Atlas (TCGA),...
8.
Lan R, Zhang K, Niu T, You Z
Am J Clin Exp Urol
. 2020 Jan;
7(6):352-377.
PMID: 31970232
Interleukin-17 () has been shown to promote development of hormone-naïve prostate cancer (HNPC) and castration-resistant prostate cancer (CRPC) as well as lymph node metastasis in mouse models. Gene alterations of...
9.
Duan Z, Miller H, Fu X, Ge D, Jin B, Moustafa A, et al.
Am J Clin Exp Urol
. 2019 Sep;
7(4):249-261.
PMID: 31511831
Interleukin-17 (IL-17) has been demonstrated to promote development of a variety of cancers including prostate cancer in genetically modified mouse models. IL-17 is the main product secreted by T helper...